BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 26198315)

  • 21. Targeting the mitochondrial pathway to induce apoptosis/necrosis through ROS by a newly developed Schiff's base to overcome MDR in cancer.
    Basu S; Ganguly A; Chakraborty P; Sen R; Banerjee K; Chatterjee M; Efferth T; Choudhuri SK
    Biochimie; 2012 Jan; 94(1):166-83. PubMed ID: 22037022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of a series of flavone derivatives as potential radioligands for imaging the multidrug resistance-associated protein 1 (ABCC1/MRP1).
    Mavel S; Dikic B; Palakas S; Emond P; Greguric I; de Gracia AG; Mattner F; Garrigos M; Guilloteau D; Katsifis A
    Bioorg Med Chem; 2006 Mar; 14(5):1599-607. PubMed ID: 16263302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytotoxic and multidrug resistance reversal activities of novel 1,4-dihydropyridines against human cancer cells.
    Shekari F; Sadeghpour H; Javidnia K; Saso L; Nazari F; Firuzi O; Miri R
    Eur J Pharmacol; 2015 Jan; 746():233-44. PubMed ID: 25445037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel manganese complex, Mn-(II) N-(2-hydroxy acetophenone) glycinate overcomes multidrug-resistance in cancer.
    Ghosh RD; Banerjee K; Das S; Ganguly A; Chakraborty P; Sarkar A; Chatterjee M; Choudhuri SK
    Eur J Pharm Sci; 2013 Jul; 49(4):737-47. PubMed ID: 23665413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complete reversal by thaliblastine of 490-fold adriamycin resistance in multidrug-resistant (MDR) human breast cancer cells. Evidence that multiple biochemical changes in MDR cells need not correspond to multiple functional determinants for drug resistance.
    Chen G; Waxman DJ
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1271-7. PubMed ID: 7562498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PHII-7 inhibits cell growth and induces apoptosis in leukemia cell line K562 as well as its MDR- counterpart K562/A02 through producing reactive oxygen species.
    Peng H; Yuan X; Shi R; Wei X; Ren S; Yan C; Ding Y; Lin Y; Fan D; Yang M; Zhang Y; Xiong D
    Eur J Pharmacol; 2013 Oct; 718(1-3):459-68. PubMed ID: 23911883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquisition of MDR phenotype by leukemic cells is associated with increased caspase-3 activity and a collateral sensitivity to cold stress.
    Cerezo D; Lencina M; Ruiz-Alcaraz AJ; Ferragut JA; Saceda M; Sanchez M; Cánovas M; García-Peñarrubia P; Martín-Orozco E
    J Cell Biochem; 2012 Apr; 113(4):1416-25. PubMed ID: 22173742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Collateral sensitivity of human melanoma multidrug-resistant variants to the polyamine analogue, N1,N11-diethylnorspermine.
    Porter CW; Ganis B; Rustum Y; Wrzosek C; Kramer DL; Bergeron RJ
    Cancer Res; 1994 Nov; 54(22):5917-24. PubMed ID: 7954423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 20(S)-Protopanaxadiol (PPD) analogues chemosensitize multidrug-resistant cancer cells to clinical anticancer drugs.
    Liu J; Wang X; Liu P; Deng R; Lei M; Chen W; Hu L
    Bioorg Med Chem; 2013 Jul; 21(14):4279-87. PubMed ID: 23683834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of multidrug resistance by small interfering double-stranded RNAs in ovarian cancer cells.
    Zhang T; Guan M; Jin HY; Lu Y
    Gynecol Oncol; 2005 May; 97(2):501-7. PubMed ID: 15863151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of the multidrug resistance transporter P-glycoprotein in multicellular tumor spheroids by hypoxia-inducible factor (HIF-1) and reactive oxygen species.
    Wartenberg M; Ling FC; Müschen M; Klein F; Acker H; Gassmann M; Petrat K; Pütz V; Hescheler J; Sauer H
    FASEB J; 2003 Mar; 17(3):503-5. PubMed ID: 12514119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxicity studies of some novel fluoro acridone derivatives against sensitive and resistant cancer cell lines and their mechanistic studies.
    Rajendra Prasad VV; Peters GJ; Lemos C; Kathmann I; Mayur YC
    Eur J Pharm Sci; 2011 Jul; 43(4):217-24. PubMed ID: 21565270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ANTIPSYCHOTICS REVERSE P-GLYCOPROTEIN-MEDIATED DOXORUBICIN RESISTANCE IN HUMAN UTERINE SARCOMA MES-SA/Dx5 CELLS: A NOVEL APPROACH TO CANCER CHEMOTHERAPY.
    Angelini A; Ciofani G; Conti P
    J Biol Regul Homeost Agents; 2015; 29(2):357-65. PubMed ID: 26122223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor agents 260. New desmosdumotin B analogues with improved in vitro anticancer activity.
    Nakagawa-Goto K; Bastow KF; Chen TH; Morris-Natschke SL; Lee KH
    J Med Chem; 2008 Jun; 51(11):3297-303. PubMed ID: 18473435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel indirubin derivative PHII-7 potentiates adriamycin cytotoxicity via inhibiting P-glycoprotein expression in human breast cancer MCF-7/ADR cells.
    Shi R; Li W; Zhang X; Zhang Y; Peng H; Xie Y; Fan D; Liu R; Liu X; Xiong D
    Eur J Pharmacol; 2011 Nov; 669(1-3):38-44. PubMed ID: 21871878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of the transport function of membrane proteins by some substituted phenothiazines in E. coli and multidrug resistant tumor cells.
    Molnár J; Hevér A; Fakla I; Fischer J; Ocsovski I; Aszalós A
    Anticancer Res; 1997; 17(1A):481-6. PubMed ID: 9066699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
    Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anti-cancer drug resistance and glutathione S-transferases].
    Sato K; Tsuchida S; Tamai K
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):592-8. PubMed ID: 2650631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax.
    Li X; Hong L; Zhao Y; Jin H; Fan R; Du R; Xia L; Luo G; Fan D
    Biochem Cell Biol; 2007 Dec; 85(6):741-50. PubMed ID: 18059532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.